2,371
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Potential role of a three-gene signature in predicting diagnosis in patients with myocardial infarction

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 2734-2749 | Received 30 Mar 2021, Accepted 31 May 2021, Published online: 15 Jun 2021

References

  • Liu K, Zhao D, Wang D. LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis. Bioengineered. 2020;11(1):11–18.
  • Wang C, Jing Q. Non-coding RNAs as biomarkers for acute myocardial infarction. Acta Pharmacol Sin. 2018;39(7):1110–1119.
  • Liu N, Zheng F, Zheng X. Detection of biomarkers of acute myocardial infarction by high-throughput suspension array technology in serum sample. Bioanalysis. 2018;10(1):47–58.
  • Zhao J, Yu H, Yan P, et al. Circulating microRNA-499 as a diagnostic biomarker for acute myocardial infarction: a meta-analysis. Dis Markers. 2019;2019:6121696.
  • de Winter RJ, Koster RW, Sturk A, et al. Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room. Circulation. 1995;92(12):3401–3407.
  • Chan D, Ng LL. Biomarkers in acute myocardial infarction. BMC Med. 2010;8:34.
  • Christenson RH, Vollmer RT, Ohman EM, et al. Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI study group. Am J Cardiol. 2000;85(5):543–547.
  • Rakowski T, Dziewierz A, Legutko J, et al. Creatine kinase-MB assessed in patients with acute myocardial infarction correlates with cardiac magnetic resonance infarct size at 6-month follow up. Hellenic J Cardiol. 2014;55(1):4–8.
  • Chen DQ, Kong XS, Shen XB, et al. Identification of differentially expressed genes and signaling pathways in acute myocardial infarction based on integrated bioinformatics analysis. Cardiovasc Ther. 2019;2019:8490707.
  • Cheng Q, Zhang M, Zhang M, et al. Long non-coding RNA LOC285194 regulates vascular smooth muscle cell apoptosis in atherosclerosis. Bioengineered. 2020;11(1):53–60.
  • Gobbi G, Carubbi C, Tagliazucchi GM, et al. Sighting acute myocardial infarction through platelet gene expression. Sci Rep. 2019;9(1):19574.
  • Park HJ, Noh JH, Eun JW, et al. Assessment and diagnostic relevance of novel serum biomarkers for early decision of ST-elevation myocardial infarction. Oncotarget. 2015;6(15):12970–12983.
  • Zdenek Valenta IM, Kolar M, Grunfeldova H, et al. Determinants of excess genetic risk of acute myocardial infarction-a matched case-control study. Eur J Biomed Inform. 2012;8(1):34–43.
  • Muse ED, Kramer ER, Wang H, et al. A whole blood molecular signature for acute myocardial infarction. Sci Rep. 2017;7(1):12268.
  • Wang Y, Chen L, Ju L, et al. Tumor mutational burden related classifier is predictive of response to PD-L1 blockade in locally advanced and metastatic urothelial carcinoma. Int Immunopharmacol. 2020;87:106818.
  • Fang Q, Wang Q, Zhou Z, et al. Consensus analysis via weighted gene co-expression network analysis (WGCNA) reveals genes participating in early phase of acute respiratory distress syndrome (ARDS) induced by sepsis. Bioengineered. 2021;12(1):1161–1172.
  • Emanuelsson O, Brunak S, von Heijne G, et al. Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc. 2007;2(4):953–971.
  • Bendtsen JD, Nielsen H, von Heijne G, et al. Improved prediction of signal peptides: signalP 3.0. J Mol Biol. 2004;340(4):783–795.
  • Obuchowski NA, McClish DK. Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices. Stat Med. 1997;16(13):1529–1542.
  • Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287.
  • Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882–893.
  • Dwamena BA. Midas: a program for meta-analytical integration of diagnostic accuracy studies in stata. University of Michigan; 2007. Available from: http://sitemaker.umich.edu/metadiagnosis/midas_home
  • Zamora J, Abraira V, Muriel A, et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.
  • Zhang R, Ji Z, Qu Y, et al. Clinical value of ARG1 in acute myocardial infarction patients: bioinformatics-based approach. Biomed Pharmacother. 2020;121:109590.
  • Zhu Y, Hu C, Du Y, et al. Time-dependent change in omentin-1 level correlated with early improvement of myocardial function in patients with first anterior ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. J Atheroscler Thromb. 2019;26(10):856–867.
  • Lin CF, Su CJ, Liu JH, et al. Potential effects of CXCL9 and CCL20 on cardiac fibrosis in patients with myocardial infarction and isoproterenol-treated rats. J Clin Med. 2019;8(5). DOI:10.3390/jcm8050659
  • Orrem HL, Shetelig C, Ueland T, et al. Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction. Int J Cardiol. 2018;268:187–192.
  • Chang SL, Hsiao YW, Tsai YN, et al. Interleukin-17 enhances cardiac ventricular remodeling via activating MAPK pathway in ischemic heart failure. J Mol Cell Cardiol. 2018;122:69–79.
  • Nagasaka A, Mogi C, Ono H, et al. The proton-sensing G protein-coupled receptor T-cell death-associated gene 8 (TDAG8) shows cardioprotective effects against myocardial infarction. Sci Rep. 2017;7(1):7812.
  • Stejskal D, Vaclavik J, Smekal A, et al. Omentin-1 levels in patients with premature coronary artery disease, metabolic syndrome and healthy controls. Short communication. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016;160(2):219–221.
  • Safa A, Rashidinejad HR, Khalili M, et al. Higher circulating levels of chemokines CXCL10, CCL20 and CCL22 in patients with ischemic heart disease. Cytokine. 2016;83:147–157.
  • Menzel J, Di Giuseppe R, Biemann R, et al. Omentin-1 and risk of myocardial infarction and stroke: results from the EPIC-Potsdam cohort study. Atherosclerosis. 2016;251:415–421.
  • Kadoglou NP, Tahmatzidis DK, Giannakoulas C, et al. Serum levels of novel adipokines, omentin-1 and chemerin, in patients with acute myocardial infarction: KOZANI STUDY. J Cardiovasc Med (Hagerstown). 2015;16(5):341–346.
  • Kataoka Y, Shibata R, Ohashi K, et al. Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms. J Am Coll Cardiol. 2014;63(24):2722–2733.
  • Yan X, Shichita T, Katsumata Y, et al. Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction. J Am Heart Assoc. 2012;1(5):e004408.
  • Lian Z, Lv FF, Yu J, et al. The anti-inflammatory effect of microRNA-383-3p interacting with IL1R2 against homocysteine-induced endothelial injury in rat coronary arteries. J Cell Biochem. 2018;119(8):6684–6694.
  • Yabluchanskiy A, Ma Y, DeLeon-Pennell KY, et al. Myocardial infarction superimposed on aging: MMP-9 deletion promotes M2 macrophage polarization. J Gerontol A Biol Sci Med Sci. 2016;71(4):475–483.
  • Mohammad MA, Noc M, Lang I, et al. Proteomics in hypothermia as adjunctive therapy in patients with ST-segment elevation myocardial infarction: a CHILL-MI Substudy. Ther Hypothermia Temp Manag. 2017;7(3):152–161.
  • Fu Q, Mo TR, Hu XY, et al. miR-19a mitigates hypoxia/reoxygenation-induced injury by depressing CCL20 and inactivating MAPK pathway in human embryonic cardiomyocytes. Biotechnol Lett. 2021;43(2):393–405.
  • Kim J, Tomalin L, Lee J, et al. Reduction of inflammatory and cardiovascular proteins in the blood of patients with psoriasis: differential responses between tofacitinib and etanercept after 4 weeks of treatment. J Invest Dermatol. 2018;138(2):273–281.
  • Smékal A, Václavík J, Stejskal D, et al. Plasma levels and leucocyte RNA expression of adipokines in young patients with coronary artery disease, in metabolic syndrome and healthy controls. Cytokine. 2019;122:154017.
  • Shibata R, Ouchi N, Kikuchi R, et al. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis. 2011;219(2):811–814.
  • Baig M, Alghalayini KW, Gazzaz ZJ, et al. Association of serum omentin-1, chemerin, and leptin with acute myocardial infarction and its risk factors. Pak J Med Sci. 2020;36(6):1183–1188.
  • Alkuraishy HM, Al-Gareeb AI. New insights into the role of metformin effects on serum omentin-1 levels in acute myocardial infarction: cross-sectional study. Emerg Med Int. 2015;2015:283021.
  • Preiss D, Lloyd SM, Ford I, et al. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes Endocrinol. 2014;2(2):116–124.